# Pilot Investigation of Stem Cells in Stroke Phase II Efficacy

> **NCT02117635** · PHASE2 · COMPLETED · sponsor: **ReNeuron Limited** · enrollment: 23 (actual)

## Conditions studied

- Ischaemic Stroke
- Cerebral Infarction
- Hemiparesis
- Arm Paralysis

## Interventions

- **BIOLOGICAL:** CTX DP

## Key facts

- **NCT ID:** NCT02117635
- **Lead sponsor:** ReNeuron Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2016-10-31
- **Final completion:** 2017-08-16
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2018-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02117635

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02117635, "Pilot Investigation of Stem Cells in Stroke Phase II Efficacy". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT02117635. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*